> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# AngioDynamics' 10-Q Details Honroth CEO Handoff As Cash Falls To $33.97 Million
- URL: https://www.bullished.co/angiodynamics-names-eric-honroth-ceo-in-10-q-note-as-cash-falls-to-33-97-million-533b2545/
- Published: 2026-10-08T17:05:54.000Z
- Updated: 2026-10-09T10:17:53.000Z
- Description: The 10-Q's subsequent-events note says Honroth succeeds Jim Clemmer on November 2, while cash fell from $53.86 million at May 31.
- Author: Matteo Parrino
- Tags: SEC Filings, ANGO, Industry: Healthcare

[AngioDynamics](https://www.bullished.co/tag/ango/), which announced Eric Honroth as its next president and CEO in an [8-K](https://www.sec.gov/Archives/edgar/data/1275187/000114036126039019/ef20083270%5F8k.htm?ref=bullished.co) on October 8, details the November 2 handoff in a subsequent-events note to its [10-Q](https://www.sec.gov/Archives/edgar/data/0001275187/000162828026065423/ango-20260831.htm?ref=bullished.co) for the quarter ended August 31\. He succeeds Jim Clemmer, who signed a consulting agreement on October 5 and leaves the board the same day Honroth starts.

## What the filing says about the handoff

The note says the company announced Honroth's appointment on October 8, as president, CEO and a board member. Clemmer will retire, and his employment ends on November 2.

The October 5 consulting agreement keeps Clemmer on as an adviser for one year from the effective date, though it can end earlier. The filing says the arrangement is meant to support continuity and a smooth transition.

The transition has already cost money. The restructuring line carries a $770 thousand "CEO transition" charge, covering retirement and transition expenses, the CEO search and retention agreements with the executive team. The prior-year quarter had none. The filing, like the prior 10-Q, calls Clemmer's retirement upcoming and dates its announcement to January 6, 2026.

## Cash fell $19.9 million in the quarter

Cash stood at $33.97 million on August 31, down from $53.86 million at May 31\. Operating activities used $15.33 million, versus $15.91 million a year earlier.

Paying down payables, accrued and other liabilities took $17.4 million, compared with $10.7 million in the year-earlier period. Accrued payroll fell to $14.4 million from $24.9 million at May 31.

The company still says cash on hand covers its needs for at least the next 12 months. Its $25.0 million revolving credit facility had nothing outstanding at August 31, and the credit agreement has a two-year maturity from its May 28, 2025 signing.

## Operating results and the stock

Revenue rose 6.9% to $80.9 million. Net loss narrowed to $7.1 million, or $0.17 a share, from $10.9 million, or $0.26\. Gross margin was 59.4%, and tariff refunds of $1.2 million helped it.

Backlog was $2.7 million at August 31, versus $0.3 million at February 28, per the [prior 10-Q](https://www.sec.gov/Archives/edgar/data/0001275187/000162828026023008/ango-20260228.htm?ref=bullished.co). It now affects Port products as well as Core.

Shares traded at $11.46 in Thursday trading, down about 19% from the $14.19 prior close (market data).

The next date is November 2, when Honroth takes over and Clemmer leaves the board.

*Correction, October 9, 2026: An earlier version of this story said AngioDynamics named its new CEO in a 10-Q note. The appointment was announced earlier the same day in an 8-K; Jim Clemmer's retirement was first announced January 6, 2026\. It also said either side could end Clemmer's consulting agreement early; the filings say only that it can end earlier.*

### Sources

- [10-Q Filing — AngioDynamics (ANGO)](https://www.sec.gov/Archives/edgar/data/0001275187/000162828026065423/ango-20260831.htm?ref=bullished.co) — SEC EDGAR
- [10-Q Filing — AngioDynamics (ANGO), Q3 FY2026 filed 2026-04-02 (comparison basis)](https://www.sec.gov/Archives/edgar/data/0001275187/000162828026023008/ango-20260228.htm?ref=bullished.co) — SEC EDGAR
- [10-K Filing — AngioDynamics (ANGO), filed 2026-07-14 (earlier disclosure)](https://www.sec.gov/Archives/edgar/data/0001275187/000162828026048138/ango-20260531.htm?ref=bullished.co) — SEC EDGAR
- [AngioDynamics Q1 2027 Earnings Call: Complete Transcript](https://www.benzinga.com/news/26/10/62245059/angiodynamics-q1-2027-earnings-call-complete-transcript?ref=bullished.co) — benzinga.com
- [AngioDynamics: Fiscal Q1 Earnings Snapshot – WTOP News](https://wtop.com/national/2026/10/angiodynamics-fiscal-q1-earnings-snapshot/?ref=bullished.co) — wtop.com
- [AngioDynamics Affirms FY2027 Adj EPS Guidance...](https://www.benzinga.com/news/26/10/62239329/angiodynamics-affirms-fy2027-adj-eps-guidance-0-29-0-24-vs-0-27-est-affirms-fy2027-sales-guidance-33?ref=bullished.co) — benzinga.com
- [AngioDynamics Q1 Earnings Call Highlights](https://finance.yahoo.com/healthcare/articles/angiodynamics-q1-earnings-call-highlights-140236415.html?ref=bullished.co) — Yahoo Finance
- [AngioDynamics Shares Fall 4.3% Despite Q1 Earnings Beat and Strong Med Tech Growth](https://finance.yahoo.com/healthcare/articles/angiodynamics-shares-fall-4-3-121942933.html?ref=bullished.co) — Yahoo Finance

### More on AngioDynamics

- [AngioDynamics Picks Getinge's Eric Honroth As CEO, Effective November 2, As Jim Clemmer Retires After 10 Years](https://www.bullished.co/angiodynamics-picks-getinges-eric-honroth-as-ceo-effective-november-2-as-jim-clemmer-1f422477/)
- [AngioDynamics Paid Retiring CEO Clemmer $6.1 Million As Executive Bonuses Hit 180% Of Target](https://www.bullished.co/angiodynamics-paid-retiring-ceo-clemmer-6-1-million-as-executive-bonuses-hit-180-of-target-21c4444d/)
- [AngioDynamics Cuts Quarterly Loss To $7.1 Million, Names Eric Honroth CEO And Holds Guidance](https://www.bullished.co/angiodynamics-cuts-quarterly-loss-to-7-1-million-names-eric-honroth-ceo-and-holds-guidance-779e3a53/)

[All AngioDynamics (ANGO) coverage →](https://www.bullished.co/tag/ango/)